Logo-ijhpm
Editorial

1. Universal Pharmacare in Canada: A Prescription for Equity in Healthcare
Mohammad Hajizadeh* ORCID, Sterling Edmonds
Int J Health Policy Manag. 2020;9(3): 91-95. doi: 10.15171/ijhpm.2019.93
PMCID: PMC7093046     PMID: 32202091    
Article
PDF
XML
Cited By:
Commentary

2. National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on “Universal Pharmacare in Canada: A Prescription for Equity in Healthcare”
Nigel S. B. Rawson* ORCID
Int J Health Policy Manag. 2020;9(12): 524-527. doi: 10.15171/ijhpm.2019.146
PMCID: PMC7947647     PMID: 32610769    
Article
PDF
XML
Cited By:
Commentary

3. It’s Time to Finally Kill the Zombies Comment on “Universal Pharmacare in Canada”
Joel Lexchin* ORCID
Int J Health Policy Manag. 2020;9(12): 528-530. doi: 10.15171/ijhpm.2020.03
PMCID: PMC7947650     PMID: 32610770    
Article
PDF
XML
Cited By:
Commentary

4. The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on “Pharmacare in Canada”
Kristina M. L. Acri née Lybecker* ORCID
Int J Health Policy Manag. 2021;10(3): 152-154. doi: 10.15171/ijhpm.2020.20
PMCID: PMC7947897     PMID: 32610780    
Article
PDF
XML
Cited By:
Commentary

5. Separated at Birth: The Politics of Pharmacare for All in Canada and Medicare for All in the United States Comment on “Universal Pharmacare in Canada”
Carolyn Hughes Tuohy* ORCID
Int J Health Policy Manag. 2021;10(3): 162-164. doi: 10.34172/ijhpm.2020.31
PMCID: PMC7947896     PMID: 32610786    
Article
PDF
XML
Cited By:
Commentary

6. Understanding the Battle for Universal Pharmacare in Canada Comment on “Universal Pharmacare in Canada”
Marc-André Gagnon* ORCID
Int J Health Policy Manag. 2021;10(3): 168-171. doi: 10.34172/ijhpm.2020.40
PMCID: PMC7947898     PMID: 32610789    
Article
PDF
XML
Cited By: